StockData
Celularity Inc logo

Celularity Inc (CELU) stock

CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026Score 7/30
$0.57−0.05 (-7.75%)

Close on Nov 17, 2026Market cap $18.53MP/E –Yield –

Celularity operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Celularity's operating cash flow for the twelve months ending Jun 30, 2026 was -$8.92M. For fiscal 2025 it was -$13.25M. The highest annual figure on record is -$1.10M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.25M–
FY2024Dec 31, 2024-$6.40M–
FY2023Dec 31, 2023-$38.69M–
FY2022Dec 31, 2022-$137.88M–
FY2021Dec 31, 2021-$110.10M–
FY2020Dec 31, 2020-$63.19M–
FY2019Dec 31, 2019-$1.10M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.11M–
Q1 FY2026Mar 31, 2026$1.45M–
Q4 FY2025Dec 31, 2025-$5.10M-420.1%
Q3 FY2025Sep 30, 2025-$4.16M–
Q2 FY2025Jun 30, 2025-$999.00K–
Q1 FY2025Mar 31, 2025-$2.99M–
Q4 FY2024Dec 31, 2024$1.59M–
Q3 FY2024Sep 30, 2024-$144.00K–
Q2 FY2024Jun 30, 2024-$3.45M–
Q1 FY2024Mar 31, 2024-$4.40M–
Q4 FY2023Dec 31, 2023-$4.34M–
Q3 FY2023Sep 30, 2023-$8.32M–
Q2 FY2023Jun 30, 2023-$11.03M–
Q1 FY2023Mar 31, 2023-$15.00M–
Q4 FY2022Dec 31, 2022-$29.59M–
Q3 FY2022Sep 30, 2022-$37.72M–
Q2 FY2022Jun 30, 2022-$36.32M–
Q1 FY2022Mar 31, 2022-$34.25M–
Q4 FY2021Dec 31, 2021-$32.05M–
Q3 FY2021Sep 30, 2021-$34.77M–
Q2 FY2021Jun 30, 2021-$18.20M–
Q1 FY2021Mar 31, 2021-$25.08M–
Q4 FY2020Dec 31, 2020-$16.83M–
Q3 FY2020Sep 30, 2020-$45.59M–
Q2 FY2020Jun 30, 2020-$224.43K–
Q1 FY2020Mar 31, 2020-$549.58K–
Q4 FY2019Dec 31, 2019-$223.80K–
Q3 FY2019Sep 30, 2019-$679.22K–
Q2 FY2019Jun 30, 2019-$194.13K–
Q1 FY2019Mar 31, 2019-$676–

More Celularity figures

See a number that looks wrong?